Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association
Recognizing Excellence In Endocrinology, ESE Announces The Winners Of Its Prestigious Awards For 2025
image:
Winners of the 2025 European Society of Endocrinology (ESE) Awards (Top left to bottom right): Thierry Brue (France), Krishna Chatterjee (United Kingdom), Eugenia Vlachou (Greece), Massimo Terzolo (Italy), Kashyap Patel (United Kingdom), Ana Djordjevic (Serbia), Alessandro Prete (United Kingdom).
view moreCredit: ESE
Recognising excellence in endocrinology, ESE announces the winners of its prestigious Awards for 2025
The European Society of Endocrinology (ESE) is delighted to announce the winners of the 2025 ESE Awards.
The winners of the Society's prestigious annual Awards for 2025 have all contributed to improving knowledge and expertise in endocrinology and have helped drive innovation and progression across the field.
Each of these deserving winners will be presenting a plenary lecture at the Joint Congress of ESPE and ESE 2025 which will be held in Copenhagen, Denmark, from 10-13 May 2025.
Jérôme Bertherat, President of the European Society of Endocrinology (ESE) commented: "We had some outstanding candidates for the 2025 ESE Awards. Our Award winners are exceptional, they have demonstrated great leadership and have made a huge contribution to both research and to patient care in the field of endocrinology. They are fully deserving winners of these prestigious Awards, and I know they will deliver excellent Award lectures at the Joint Congress of ESPE and ESE 2025 next May."
The 2025 Geoffrey Harris Award is being presented to Thierry Brue (France). This Award recognises outstanding researchers in the field of neuroendocrinology.
Thierry Brue, MD, PhD, is Professor of endocrinology at Aix-Marseille University (AMU, Marseille, France), and endocrinologist at the department of Endocrinology of Conception University Hospital, and coordinator of the national and European (Endo-ERN) rare disease reference centre for pituitary disorders (HYPO). Since 2019, he has been the Director of the Aix-Marseille University Institute for Rare Diseases, MarMaRa.
Thierry's research activities include clinical research in pituitary disorders, especially participation as investigator in international multicentre clinical trials, experimental research as group leader in the Marseille Medical Genetics AMU-INSERM Laboratory of Frédérique Magdinier and coordination of a research network on genetically determined pituitary hormone deficiency (GENHYPOPIT). He has co-authored 330+ articles referenced in PubMed (WoS h-index: 60+; total times cited 10000+, Google Scholars 79+), and is a member of several international societies of endocrinology, past-President (2018-2020) of the European Neuroendocrine Association (ENEA), and recipient of the Rolf-Gaillard Prize 2023.
The European Hormone Medal is awarded to an international researcher who has made significant contributions to the field of basic or clinical endocrinology. This year's Award goes to Krishna Chatterjee (United Kingdom).
Krishna Chatterjee is Professor of Endocrinology at the Institute of Metabolic Science at the University of Cambridge, Consultant Endocrinologist at Cambridge University Hospitals and Director of the National Institute for Health Research (NIHR) Cambridge Clinical Research Facility.
Krishna is distinguished for his contribution to the molecular basis of endocrine disorders and its application to clinical medicine. His discoveries of genetic disorders of thyroid gland formation, regulation of hormone synthesis and hormone action, have advanced fundamental knowledge at different levels of the thyroid axis.
He has translated his research into technologies (biochemical, genetic, biomarkers) that comprise an internationally recognised service for the diagnosis and management of disorders of thyroid hormone action and trials therapies for these conditions.
The European Endocrine Nurse Award is awarded to endocrine nurses and teams who have made a truly significant contribution to the advancement of endocrinology nursing. This year's Award is presented to Eugenia Vlachou (Greece).
Eugenia Vlachou has had a significant effect on the training of endocrine nurses in Greece, demonstrated through their great work and the treatment of patients.
Eugenia holds the position of Professor of Endocrinology and Gynaecology Nursing at the Department of Nursing in the University of West Attica, Athens, Greece. Throughout her tenure, she has held various administrative roles, contributing significantly to the academic and clinical development of the department. She is the Director of the MSc Programme on Management of Chronic Diseases, and she is also academically responsible for the specialty of Diabetes Care.
She obtained her degree in Nursing from the National and Kapodistrian University of Athens. She further pursued an MSc in Public Health and completed her PhD in Gynaecological Endocrinology at the same university. During her early career, she worked at the esteemed Endocrinology Clinics of The Evangelismos Hospital in Athens, where she received her Medical-Surgical Nursing Specialty. She later specialised in the UK in Diabetes Nursing.
Eugenia has served as a member of the Executive Committee of the Hellenic Regulatory Body of Nurses for six years, and as a member of the European Society of Endocrinology (ESE) Nurse Committee for four years. She is currently a member of the Foundation of European Nurses in Diabetes (FEND) Executive Committee and maintains active memberships in the Hellenic Endocrinology Society and the Hellenic Diabetes Society. Her extensive professional network and leadership roles reflect her dedication to advancing the field of Endocrinology and Diabetes nursing, both nationally and internationally.
The Clinical Endocrinology Journal Foundation Award is given for clinical research that addresses aspects of endocrinology at the forefront of clinical practice and is sponsored by the Clinical Endocrinology Journal Foundation. This year's Award goes to Massimo Terzolo (Italy).
Massimo Terzolo's exceptional contributions to clinical research have had a tremendous impact on adrenocortical cancer treatment to improve patient care, making him a highly deserving recipient of this Award.
Massimo Terzolo, MD, PhD, is a Full Professor of Internal Medicine at the University of Turin, where he serves as Director of the Department of Clinical and Biological Sciences and Head of the Division of Internal Medicine at University Hospital San Luigi Gonzaga in Orbassano. Massimo has significantly advanced the field of adrenal disease and endocrine oncology, particularly through his leadership in groundbreaking clinical trials.
He coordinated the pivotal ADIUVO trial on adjuvant mitotane therapy for non-metastatic adrenocortical carcinoma and was instrumental in the FIRMACT trial for advanced stages of the disease. His work has driven crucial progress in therapeutic approaches to adrenocortical carcinoma, with landmark publications in The Lancet Diabetes & Endocrinology and The New England Journal of Medicine. Additionally, he has co-authored the European Society of Endocrinology's Guidelines on Adrenocortical Carcinoma and Adrenal Incidentalomas, reinforcing best practices in endocrinology.
A leader within the European Network for the Study of Adrenal Tumors (ENSAT), Massimo heads the Adrenocortical Carcinoma working group. His prolific research, with over 270 peer-reviewed publications, has earned more than 17,000 citations, attesting to his profound impact on the field. He also serves on editorial boards for leading journals in endocrinology.
The European Journal of Endocrinology Award is presented to a candidate who has significantly contributed to the advancement of knowledge in the field of endocrinology through publication. This year's Award goes to Kashyap Patel (United Kingdom).
Kashyap Patel is a world-leading expert and highly awardable for his impressive publication record which has significantly advanced knowledge in the field of monogenic diabetes and directly benefited patients (H-index 29, citations 3771, overall median citation percentile - 81st).
Kashyap is an Associate Professor and Consultant Physician in Diabetes and Endocrinology. He is a Wellcome Trust Career Development Fellow and his main area of research includes understanding the genetics of diabetes with a focus on Monogenic and Type 1 diabetes. His research uses next-generation sequencing technology and large data sets to improve diagnosis and understanding of monogenic diabetes in humans.
He was a Wellcome Trust PhD Research Fellow in the prestigious MRC Protein Phosphorylation Unit in Dundee, where he was awarded his PhD studying the glucose metabolism in the liver. After his PhD, he obtained a Wellcome Trust Postdoctoral Fellowship to study monogenic diabetes in Exeter with Professor Andrew Hattersley and Professor Sian Ellard. He is also the recipient of prestigious Young Investigator awards from Diabetes UK and EASD-SGGD for his work in monogenic diabetes.
The Jens Sandahl Christiansen Award is presented to endocrinologists for a specific piece of research or project which contributes to our understanding of metabolism. This award is split into clinical and basic science. The recipients of the Award for 2025 are Ana Djordjevic (Serbia) for Basic Science and Alessandro Prete (United Kingdom) for Clinical Science.
Ana Djordjevic has demonstrated exceptional commitment to research and has published three book chapters and over 60 scientific papers in international journals, giving her an excellent publication score.
Ana is a Principal Research Fellow at the Institute for Biological Research Siniša Stanković (IBISS) at the University of Belgrade. She received her PhD from the Faculty of Biology at the University of Belgrade in 2010, where she completed her undergraduate studies in Molecular Biology and Physiology. She is the head of the Department of Biochemistry at IBISS, and has participated in several national and international projects, most recently in the Twinning project STRIMHealth. Ana is currently Principal Investigator of a proof-of-concept project, Probiotic bacteria for reducing liver steatosis, funded by the World Bank SAIGE project.
Ana's early research focused on stress biology, and over the last 10 years, her research has remained in the field of molecular endocrinology but has focused mainly on diet-induced metabolic disorders, particularly type 2 diabetes and obesity. She is currently the Vice President of the Serbian Society for Molecular Biology.
Alessandro Prete has an excellent publication record and must be commended for his focused and potentially impactful clinical research project.
Alessandro is a Clinical Associate Professor of Endocrinology at the Department of Metabolism and Systems Science, University of Birmingham, UK. He obtained his PhD from the same University in 2022 and is also a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, UK.
His area of research focuses on functioning adrenal tumours, endocrine hypertension, and adrenal insufficiency, combining clinical trials and experimental medicine studies. As well as receiving awards at both national and international conferences for his work, Alessandro has over 40 peer-reviewed publications.
The Transatlantic Alliance Award 2025 winner will be announced later this year. Nominations for the ESE's 2026 Awards will open in November 2024.
Cushing Disease Presenting With Hypertension In Association With Nonfunctioning Unilateral Adrenal Adenoma
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.
About The Editors
Editor-in-ChiefMichael Stowasser, PhD, MBBS, FRACP, University of Queensland, Brisbane, Australia
Michael is currently Director of the Hypertension Units and Co-Director of the Endocrine Hypertension Research Centre within the University of Queensland School of Medicine at Greenslopes and Princess Alexandra Hospitals in Brisbane. He has over 25 years clinical research experience in pathogenesis and management of hypertension and especially of endocrine varieties including primary aldosteronism, renovascular hypertension, pheochromocytoma and familial hyperkalemic hypertension. Working with mentor Richard Gordon, he helped to demonstrate that primary aldosteronism is at least 10 times more common than previously thought, and is the commonest specifically treatable and potentially curable form of hypertension. Ongoing studies are aimed at determining genetic bases for primary aldosteronism, examining non-blood pressure dependent effects of aldosterone excess, improving methods of detection, diagnostic workup and management of primary aldosteronism and exploring the pathogenesis and genetics of other salt sensitive forms of hypertension, including familial hyperkalemic hypertension.
Associate EditorsAnthony Bain, PhD, MSc, University of Windsor, Ontario, Canada
Dr. Anthony Bain is an Associate Professor in the Department of Kinesiology and adjunct Professor in Integrative Biology at the University of Windsor. He received his PhD at the University of British Columbia and post-doctoral training at the University of Colorado Boulder. Dr. Bain specializes in integrative cerebral vascular and endothelial physiology, with particular focus on the responses to hypoxia, exercise and hyperthermia. His most recent research involves understanding the endothelial mechanisms associated with the responses and adaptations to vascular wall shear stress. Dr. Bain is a member of the Physical Activity and Cardiovascular Research (PACR) group as well as the WESPARK Health Institute. His research program is primarily funded through the National Science and Engineering Research Council of Canada (NSERC).
J. Brian Byrd, MD, MS, FAHA, FACC, University of Michigan School of Medicine, Michigan, USA
Dr. J. Brian Byrd investigates human hypertension using laboratory investigation of novel biomarkers, clinical trials, and epidemiology. While training in Nancy J. Brown's laboratory, he worked on the mechanism of ACE inhibitor-associated angioedema in a rodent model, a case-control study, a GWAS, and a randomized clinical trial of a new drug. He later served as an investigator for the SYMPLICITY HTN-3 pivotal clinical trial of renal artery denervation. His current interest is resistant hypertension, especially endocrine forms of hypertension. Recently, his laboratory has pioneered sensitive and specific assays to detect mineralocorticoid receptor-regulated gene expression in the supernatant of human urine. In addition, Dr. Byrd worked together with a group dedicated to improving the quality of studies involving exosomes, nanoscale vesicles secreted into biofluids that provide a novel source of physiologically relevant biomarkers, the work having now been published in Nature Methods. Beyond these and other research contributions, in 2017 Dr. Byrd and Casey Greene created the Research Symbiont Awards, which recognize excellence in data sharing. He is a principal investigator at the University of Michigan School of Medicine, where he is Assistant Professor in the Department of Internal Medicine's Division of Cardiovascular Medicine. He is funded by several organizations, including the National Institutes of Health.
Fadi Charchar, PhD, FAHA, Federation University, Ballarat, Australia
Professor Fadi Charchar is the Robert HT Smith Chair in Cardiovascular Genomics and Dean, Graduate Research School at Federation University. Professorial Research Fellow at the University of Melbourne and Visiting Chair at University of Leicester, UK. Professor Charchar is the Vice-President of the International Society of Hypertension and President of the International Society of Heart Research. He previously completed a Wellcome Trust Fellowship and a British Heart Foundation Lectureship in the UK. He is an internationally recognized expert in understanding the genetic mechanisms of cardiovascular disease. His research includes findings that the human Y chromosome contributes to hypertension and CAD.
Christian Delles, MD, FRCP, FAHA, FBIHS, University of Glasgow, Glasgow, United Kingdom
Christian Delles is Professor of Cardiovascular Prevention and Deputy Director of the Institute for Cardiovascular and Medical Sciences, University of Glasgow; and Honorary Consultant Physician with NHS Greater Glasgow & Clyde. His research is in the area of vascular biology with oxidative stress and endothelial function as pathogenetic factors of hypertension and other cardiovascular disorders. As such he studies markers for early diagnosis of a wide range of conditions including diabetic nephropathy; the molecular basis of vascular and renal diseases; the pathogenesis and long-term consequences of hypertensive disorders of pregnancy and gestational diabetes; and differences in the pathophysiology of cardiovascular diseases between men and women. Christian serves as Treasurer of the British and Irish Hypertension Society and Honorary Secretary of the Association of Physicians of Great Britain and Ireland. He is a member of national and international grant panels, associate editor and member of the editorial board of leading cardiovascular journals and has published more than 230 peer reviewed papers.
Sunil Nadar, MD, FESC, Dudley group of hospitals NHS trust UK, Dudley, United Kingdom
Dr Sunil Nadar is a consultant interventional cardiologist at the Dudley group of hospitals NHS trust UK, having worked previously at Sultan Qaboos University Hospital, Muscat, Oman and the Heart of England NHS trust as a consultant cardiologist and an honorary senior lecturer with the University of Birmingham UK. During his time in Oman he was listed on google scholar as one of the top ten researchers in Oman in 2016.He had completed his postgraduate research with Professor Gregory Lip and Professor Gareth Beevers at the University of Birmingham UK, on hypertension and platelet function and has co-edited a book on Hypertension with Prof Lip.His main research interests are platelet activation, hypertension, coronary artery disease, and coronary intervention. He is a fellow of the Royal college of physicians London and a Fellow of the European Society of cardiology.
Pantelis Sarafidis, MD, MSc, PhD, Aristotle University of Thessaloniki, Thessaloniki, Greece
Dr Sarafidis, MD, MSc, PhD is an Associate Professor in Nephrology at Aristotle University of Thessaloniki, and Consultant in Nephrology in Hippokration Hospita. He is the Head of the ESH Hypertension Excellence Center in this hospital. He received his MD degree from Aristotle University of Thessaloniki and a MSc in Health Units Administration from Hellenic Open University. Dr Sarafidis completed his training in Nephrology in the 1st Department of Medicine, AHEPA Hospital, where he also completed his PhD thesis on the relationship of Metabolic Syndrome with Hypertension and Kidney Disease between 2001-2005. He completed two yearly post-doc fellowships in the Hypertension/Clinical Research Center, Rush University Medical Center, Chicago and the Department of Renal Medicine, King's College Hospital, London. In 2008 he received the title ESH Clinical Hypertension Specialist.During the past 18 years, the clinical and research activities of Dr Sarafidis have been focused on hypertension, diabetic and hypertensive nephropathy, acute kidney injury, anemia in CKD, polycystic kidney disease and CVD in ESRD patients. He has participated as principal or sub-investigator in numerous observational studies and clinical trials in the above fields. He has authored more than 240 articles in peer-reviewed international medical journals and book chapters in international textbooks, and performed more than 200 lectures in national and international meetings in the areas of Nephrology, Hypertension and related fields. He is currently a reviewer for more than 60 international medical journals and serves on the Editorial Board of five. Dr Sarafidis has received several awards and grants from national and international Medical Societies for his research activities.
James Sharman, PhD, Menzies Institute for Medical Research, Hobart, Australia
James is a medical researcher in the field of blood pressure and cardiovascular disease. He is Deputy Director and heads the Blood Pressure Research Group at the Menzies Institute for Medical Research, Hobart, Australia. He is also the Scientific Director of the Menzies Blood Pressure Clinic and former head of the Cardiometabolic Research Theme at Menzies. His research program has focused on the physiology and clinical relevance of central aortic blood pressure and exercise haemodynamics, as well as new methods to improve cardiovascular risk management. He currently co-leads an initiative to improve the global availability of blood pressure devices that have been clinically validated for accuracy.
Gloria Valdes, MD, Pontificia Universidad Catolica de Chile, Santiago, Chile
Gloria Valdes is now Professor Emeritus of the Faculty of Medicine of the Pontificia Universidad Católica de Chile and integrates the Chilean Academy of Medicine. After training in Nephrology in Chile and in Hypertension at the Cleveland Clinic she focused on hypertension in patient care and pre- and postgraduate teaching, acquiring a national and Latin American influence. Her laboratory research on the role of vasodilators in the systemic and local adaptations of pregnancy went from increased renal kallikrein excretion in normal pregnant women to the localization of kallikrein and the main bradykinin receptor (B2R), eNOS and vasodilators within the RAS in human and guinea-pig utero-placental interphase. From enhanced trophoblast migration by stimulating the B2R to impaired trophoblast invasion and blood pressure in guinea-pigs by inhibiting it. She took part in showing endothelial dysfunction after preeclampsia and recurrent abortion and increased coronary lesions in women far from hypertensive pregnancies. Her present interest is promoting prolonged follow-up of hypertensive pregnant women and of low birth weight/premature babies to reduce cardiovascular and renal diseases.
Yuichiro Yano, MD, Duke University School of Medicine, Durham, USA
Yuichiro Yano, MD, PhD, is Assistant Professor at the Duke University School of Medicine. As a physician scientist he has been conducting prospective observational and interventional studies using clinic, home, and 24-hour ambulatory blood pressure monitoring in Japan and the U.S. He has also been conducting research on the etiology and outcomes of abnormal blood pressure phenotypes, longitudinal modeling of cardiovascular risks, and cardiovascular disease risk prediction among young adults. He has authored or co-authored more than 100 publications in peer reviewed journals in the field, including Journal of the American Medical Association (JAMA). In 2016 he received the American Society of Hypertension's Young Scholar Award and the Sandra A. Daugherty Award from the American Heart Association. In 2017 he received the Hypertension Top Paper Award. He was recently recognized by the American Heart Association for authoring one of the most impactful publications of 2018, and received Japanese Society of Hypertension Academic Award 2019.
BIHS RepresentativeDr Sarah Partridge, BN, MSc, PhD, University of Sussex, Brighton, UK
Social Media EditorCarlos Valencia-Hernández, MD, MPH, University College London, United Kingdom
Comments
Post a Comment